Leucovorin Calcium NDC 60687-227

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-227Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0227Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-227-94	60687022794	20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-227-94) / 1 TABLET in 1 BLISTER PACK (60687-227-11)Marketed from Feb 17, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Leucovorin Calcium
Generic name (nonproprietary): leucovorin calcium
Active ingredients: Leucovorin calcium — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 071199
Marketing start: Feb 17, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Folic Acid (Chemical structure)
Identifiers: Product ID 60687-227_5590684c-f17e-9a5b-e063-6294a90af0d5SPL ID 5590684c-f17e-9a5b-e063-6294a90af0d5SPL set ID f7004cbd-9827-466e-9683-adce4f13c6a6RxCUI 197862UNII RPR1R4C0P4
Pharmacologic class: Folate Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687022794 followed by a unit qualifier and the quantity

Package 60687-0227-94. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Leucovorin calcium tablets are indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 071199

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 071199
Product	Strength	Form · route	Labeler	Product NDC
Leucovorin Calcium	Leucovorin calcium 25 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0555-0485